K

Kymera Therapeutics
D

KYMR

44.910
USD
1.31
(3.00%)
مغلق
حجم التداول
22,010
الربح لكل سهم
-3
العائد الربحي
-
P/E
-19
حجم السوق
2,908,608,455
الأخبار

العنوان: Kymera Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.